Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Gysembergh, Anne ^a   Lemaire, Stéphanie ^b   Piot, Christophe ^b   Sportouch, Catherine ^b   Richard, Sylvain ^b   Kloner, Robert A ^a   Przyklenk, Karin ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CNRS   (France)

^c GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

2 aminoethoxydiphenyl borate; Calcium; Myocardial infarction; Myocardial ischemia; Signal transduction

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; DOWN REGULATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

EID: 0033379025     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.6.h2458     Document Type: Article

References (48)

1. Abdelouahed, M., S. Emadi, I. Elalamy, M. M. Samama, and M. Hatmi. Signal transduction in the platelet activation induced by IgG anti-streptokinase and anisoylated plasminogen-streptokinase activator complex. Platelets 8: 135-141, 1997.
2. Baines, C. P., L. Wang, M. V. Cohen, and J. M. Downey. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J. Mol. Cell. Cardiol. 30: 383-392, 1998.
3. Banerjee, A., C. Locke Winter, K. B. Rogers, M. B. Mitchell, E. C. Brew, C. B. Cairns, D. D. Bensard, and A. H. Harken. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha-1-adrenergic mechanism. Circ. Res. 73: 656-670, 1993.
4. Bankwala, Z., S. L. Hale, and R. A. Kloner. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 90: 1023-1028, 1994.
5. Bauer, B., B. Z. Simkhovich, R. A. Kloner, and K. Przyklenk. Preconditioning-induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart. Basic Res. Cardiol. 94: 31-40, 1999.
6. Berridge, M. J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem 56: 159-193, 1987.
7. Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361: 315-325, 1993.
8. 3 release. Circulation 91: 2712-2716, 1995.
9. Fedida, D., A. Braun, and W. R. Giles. Alpha-1-adrenoreceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol. Rev. 73: 469-487, 1993.
10. 3 receptor with the plasma membrane: relevance to mode of action. Am. J. Physiol. 265 (Cell Physiol. 34): C1588-C1596, 1993.
11. Forbes, M. S., and N. Sperelakis. Intercalated discs of mammalian heart: a review of structure and function. Tissue Cell 17: 605-648, 1985.
12. Gerardo, J. A., and R. M. Lust. Ischemic preconditioning attenuates protein kinase C δ and ∈ isoform responses to ischemia/reperfusion (Abstract). Circulation 98, Suppl. I: I-586 1998.
13. 3-receptor in the rat suprachiasmatic nucleus on circadian entrainment mechanism. Neurosci. Lett. 263: 125-128, 1999.
14. Hamill, O. P., and D. W. McBride, Jr. The pharmacology of mechanogated membrane ion channels. Pharmacol. Rev. 48: 231-252, 1996.
15. 3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science 257: 815-818, 1992.
16. Khan, A. A., J. P. Steiner, and S. H. Snyder. Plasma membrane inositol 1,4,5-trisphosphate receptor of lymphocytes: selective enrichment in sialic acid and unique binding specificity. Proc. Natl. Acad. Sci. USA 89: 2849-2853, 1992.
17. Kijima, Y., A. Saito, T. L. Jetton, M. A. Magnuson, and S. Fleischer. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J. Biol. Chem. 268: 3499-3506, 1993.
18. Kouchi, I., T. Murakami, R. Nawada, M. Akao, and S. Sasayama. KATP channels are common mediators of ischemic and calcium preconditioning in rabbits. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H1106-H1112, 1998.
19. Lasley, R. D., M. A. Noble, and R. M. Mentzer. Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J. Mol. Cell. Cardiol. 29: 3345-3356, 1997.
20. 18 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
21. Liu, Y., K. Ytrehus, and J. M. Downey. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J. Mol. Cell. Cardiol. 26: 661-668, 1994.
22. 2+ release. J. Biochem. (Tokyo) 122: 498-505, 1997.
23. Maulik, N., M. Watanabe, Y. L. Zu, C. K. Huang, G. A. Cordis, J. A. Schley, and D. K. Das. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396: 233-237, 1996.
24. Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken, and A. Banerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
25. Mizuno, T., M. Watanabe, T. Sakamoto, and M. Sunamori. L-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-trisphosphate. J. Thorac. Cardiovasc. Surg. 115: 931-936, 1998.
26. 3 levels in cardiac atria and ventricles - a comparative study. Mol. Cell. Biochem. 115: 195-202, 1992.
27. 2+ in activation of protein kinase C during ischemic preconditioning. Circulation 96: 1257-1265, 1997.
28. Ping, P., J. Zhang, Y. Qiu, X. L. Tang, S. Manchikalapudi, X. Cao, and R. Bolli. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81: 404-414, 1997.
29. Przyklenk, K., K. Hata, and R. A. Kloner. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation 96: 1305-1312, 1997.
30. Przyklenk, K., and R. A. Kloner. Ischemic preconditioning: exploring the paradox. Prog. Cardiovasc. Dis. 40: 517-547, 1998.
31. Przyklenk, K., B. Z. Simkhovich, B. Bauer, K. Hata, L. Zhao, G. T. Elliot, and R. A. Kloner. Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium? Ann. NY Acad. Sci. 874: 192-210, 1999.
32. Przyklenk, K., M. A. Sussman, B. Z. Simkhovich, and R. A. Kloner. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557, 1995.
33. Sanderson, M. J., A. C. Charles, S. Boitano, and E. R. Dirksen. Mechanisms and function of intercellular calcium signaling. Mol. Cell. Endocrinol. 98: 173-187, 1994.
34. Severs, N. J. The cardiac gap junction and intercalated disc. Int. J. Cardiol. 26: 137-173, 1990.
35. Sharp, A. H., S. H. Snyder, and S. K. Nigam. Inositol 1,4,5-trisphosphate receptors. Localization in epithelial tissue. J. Biol. Chem. 267: 7444-7449, 1992.
36. Simkhovich, B. Z., K. Przyklenk, S. L. Hale, M. Patterson, and R. A. Kloner. Direct evidence that ischemic preconditioning does not cause protein kinase C translocation in rabbit heart. Cardiovasc. Res. 32: 1064-1070, 1996.
37. Steenbergen, C., M. E. Perlman, R. E. London, and E. Murphy. Mechanism of preconditioning. Ionic alterations. Circ. Res. 72: 112-125, 1993.
38. Steinberg, S. F., L. M. Kaplan, T. Inouye, J. F. Zhang, and R. B. Robinson. Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes. J. Pharmacol. Exp. Ther. 250: 1141-1148, 1989.
39. 2+ signalling: problems and pitfalls. Trends Pharmacol. Sci. 19: 370-375, 1998.
40. Thornton, J. D., J. F. Daly, M. V. Cohen, X. M. Yang, and J. M. Downey. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ. Res. 73: 649-655, 1993.
41. 3 responses in cerebral arteries. Am. J. Physiol. 272 (Regulatory Integrative Comp. Physiol. 41): R669-R674, 1997.
42. Vahlhaus, C., R. Schulz, H. Post, R. Onallan, and G. Heusch. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ. Res. 79: 407-414, 1996.
43. Vahlhaus, C., R. Schulz, H. Post, J. Rose, and G. Heusch. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J. Mol. Cell. Cardiol. 30: 197-209, 1998.
44. Vogt, A. M., P. Htun, M. Arras, T. Podzuweit, and W. Schaper. Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res. Cardiol. 91: 389-400, 1996.
45. Wilcox, R. A., I. D. Forsythe, and T. J. McCann. Microinjection of myo-inositol(1,4,5)trisphosphate and other calcium-mobilizing agents into intact adherent cells. In: Calcium Signaling Protocols, edited by D. G. Lambert. Totowa, NJ: Humana, 1999, p. 193-208.
46. Wilcox, R. A., W. U. Primrose, S. R. Nahorski, and R. A. J. Challiss. New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharmacol. Sci. 19: 467-475, 1998.
47. 3 during myocardial ischemia and its relationship to the development of arrhythmias. J. Mol. Cell. Cardiol. 28: 2129-2138, 1996.
48. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.